Retrospective multicenter study of patients with infections caused by Enterobacteriales co-resistant to carbapenems and polymyxins who were treated with Ceftazidime/avibactam as salvage therapy
Latest Information Update: 07 Aug 2019
At a glance
- Drugs Avibactam/ceftazidime (Primary)
- Indications Gram-negative infections
- Focus Therapeutic Use
Most Recent Events
- 07 Aug 2019 New trial record
- 29 Jul 2019 Results published in the Antimicrobial Agents and Chemotherapy